Overview
Find detailed information on selected clinical trials for Neuroblastoma at Cincinnati Children's Hospital Medical Center.
There are two versions of some of the trials. While they contain the same basic information, one version is geared toward healthcare professionals and the other is geared toward families.
| Trial | Healthcare Professional Version | Family-Friendly Version |
|---|
| NANT 2001-03: A Phase I study of CEP-701 in Patients with Refractory Neuroblastoma |
Professional |
Family-Friendly |
| NANT 99-02: Modulation of Intensive Melphalan (L-PAM) by Buthionine Sulfoximine (BSO) with Autologous Stem Cell Support for Recurrent High-Risk Neuroblastoma (A Phase I Study) |
Professional |
Family Friendly |
| ADVL0319: A Phase I Study of CC-5013 in Pediatric Patients with Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome |
Professional |
Family-Friendly |
| NANT 2001-02: 131I-Metaiodobenzylguanidine (MIBG) with Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma |
Professional |
Family-Friendly |
| NANT 2004-01: A Phase I Study Of Zoledronic Acid (Zometa) with Cyclophosphamide in Children with Recurrent or Refractory Neuroblastoma and Cortical Bone Involvement |
Professional |
Family-Friendly |
| ADVL0414: A Phase Study of Temozolomide, Oral Irinotecan, and Vincristine for Children with Refractory Solid Tumors |
Professional |
Family-Friendly |
| NANT 2004-04: Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb™ (LXS) Oral Powder In Patients with Recurrent or Resistant Neuroblastoma |
Professional |
Family-Friendly |
| ADVL0416: A Phase 1 Study of SAHA In Pediatric Patients with Recurrent or Refractory Solid Tumors (Including Lymphomas) and Leukemia Followed by a Phase I Study of SAHA in Combination with 13 Cis-Retinoic Acid for Patients with Selected Recurrent/Refractory Solid Tumors |
Professional |
Family-Friendly |
| ADVL0612: A Phase I Study of Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children with Refractory Solid Tumors |
Professional |
Family-Friendly |
| NCI-07-C-0040: A Phase I Trial of the Monoclonal Antibody HGS-ETR2 (Lexatumumab) in Patients with Refractory Pediatric Solid Tumors |
Professional |
Family-Friendly |
| ANBL0621: A Phase II Trial of ABT-751 in Children with Relapsed or Refractory Neuroblastoma |
Professional |
Family-Friendly |
| ADVL0413: Phase I Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib in Children with Refractory Solid Tumors or Refractory Leukemias |
Professional |
Family-Friendly |
| ADVL0525: A Phase II Study of Pemetrexed Disodium in Young Patients With Relapsed or Refractory Solid Tumors |
Professional |
Not Available |
